14Indexed trials
canonical disease area
Obsessive-Compulsive Disorder
Intelligence
Obsessive-Compulsive Disorder intelligence: 14 indexed trials, 4 recruiting studies, 12 sponsors across 10 countries.
4Recruiting
12Sponsors
10Countries
Leading sponsors
Karolinska Institutet20 recruiting
Shanghai Mental Health Center20 recruiting
Center for Psychological Consultation10 recruiting
Gulhane Training and Research Hospital10 recruiting
McMaster University10 recruiting
Medical University of Vienna11 recruiting
University of North Carolina, Chapel Hill10 recruiting
University of Plymouth11 recruiting
University of South Florida10 recruiting
Biohaven Pharmaceuticals, Inc.10 recruiting
Yale University11 recruiting
Bradley Hospital11 recruiting
Geographic activity
United States6trials
Canada2trials
Sweden2trials
China2trials
United Kingdom2trials
Spain1trials
Italy1trials
Netherlands1trials
Austria1trials
Turkey (Türkiye)1trials
Leading interventions
Cognitive behavioral therapy (CBT)1trials
Cognitive-behavioral therapy1trials
Computer-Assisted Cognitive Behavior Therapy (BT STEPS)1trials
Exposure with Response Prevention1trials
Fluoxetine - delayed treatment1trials
Fluoxetine - immediate treatment1trials
Gradual Exposure (EXP-G)1trials
High-Definition transcranial direct current stimulation1trials
Implantation of a DBS therapy system1trials
Internet CBT1trials
Internet-delivered cognitive behavioral therapy (ICBT)1trials
TMS1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.